Your browser doesn't support javascript.
loading
HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV.
Milewska, Aleksandra; Chi, Ying; Szczepanski, Artur; Barreto-Duran, Emilia; Dabrowska, Agnieszka; Botwina, Pawel; Obloza, Magdalena; Liu, Kevin; Liu, Dan; Guo, Xiling; Ge, Yiyue; Li, Jingxin; Cui, Lunbiao; Ochman, Marek; Urlik, Maciej; Rodziewicz-Motowidlo, Sylwia; Zhu, Fengcai; Szczubialka, Krzysztof; Nowakowska, Maria; Pyrc, Krzysztof.
Afiliación
  • Milewska A; Virogenetics Laboratory of Virology, Malopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland aleksandra.milewska@uj.edu.pl k.a.pyrc@uj.edu.pl.
  • Chi Y; Microbiology Department, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.
  • Szczepanski A; NHC Key Lab of Enteric Pathogenic Microbiology, Jiangsu Provincial Centre for Disease Control & Prevention, Nanjing, Jiangsu, People's Republic of China.
  • Barreto-Duran E; Virogenetics Laboratory of Virology, Malopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland.
  • Dabrowska A; Microbiology Department, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.
  • Botwina P; Virogenetics Laboratory of Virology, Malopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland.
  • Obloza M; Virogenetics Laboratory of Virology, Malopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland.
  • Liu K; Microbiology Department, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.
  • Liu D; Virogenetics Laboratory of Virology, Malopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland.
  • Guo X; Microbiology Department, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.
  • Ge Y; Department of Physical Chemistry, Faculty of Chemistry, Jagiellonian University, Krakow, Poland.
  • Li J; Nanjing Techboon Institute of Clinical Medicine, Nanjing, Jiangsu, People's Republic of China.
  • Cui L; Nanjing Techboon Institute of Clinical Medicine, Nanjing, Jiangsu, People's Republic of China.
  • Ochman M; NHC Key Lab of Enteric Pathogenic Microbiology, Jiangsu Provincial Centre for Disease Control & Prevention, Nanjing, Jiangsu, People's Republic of China.
  • Urlik M; NHC Key Lab of Enteric Pathogenic Microbiology, Jiangsu Provincial Centre for Disease Control & Prevention, Nanjing, Jiangsu, People's Republic of China.
  • Rodziewicz-Motowidlo S; NHC Key Lab of Enteric Pathogenic Microbiology, Jiangsu Provincial Centre for Disease Control & Prevention, Nanjing, Jiangsu, People's Republic of China.
  • Zhu F; NHC Key Lab of Enteric Pathogenic Microbiology, Jiangsu Provincial Centre for Disease Control & Prevention, Nanjing, Jiangsu, People's Republic of China.
  • Szczubialka K; Department of Cardiac, Vascular and Endovascular Surgery and Transplantology, Silesian Centre for Heart Diseases, Medical University of Silesia in Katowice, Zabrze, Poland.
  • Nowakowska M; Department of Cardiac, Vascular and Endovascular Surgery and Transplantology, Silesian Centre for Heart Diseases, Medical University of Silesia in Katowice, Zabrze, Poland.
  • Pyrc K; Department of Biomedical Chemistry, Faculty of Chemistry, University of Gdansk, Gdansk, Poland.
J Virol ; 95(4)2021 01 28.
Article en En | MEDLINE | ID: mdl-33219167

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Infecciones por Coronavirus / Quitosano / Coronavirus del Síndrome Respiratorio de Oriente Medio / SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 / Compuestos de Amonio Cuaternario Límite: Humans Idioma: En Revista: J Virol Año: 2021 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Infecciones por Coronavirus / Quitosano / Coronavirus del Síndrome Respiratorio de Oriente Medio / SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 / Compuestos de Amonio Cuaternario Límite: Humans Idioma: En Revista: J Virol Año: 2021 Tipo del documento: Article